Overview & Introduction
Tarek El-Toukhy, Module Lead
This study day aims to give information on providing PGT as part of a multidisciplinary service delivered by genetic and ART specialists. It will allow attendees to appreciate the burden of genetic disorders and their mode of inheritance whilst acquiring the latest knowledge on reproductive options for couples who are at risk of having a child affected by a genetic disorder. It will also discuss the application of PGS as an option to patients seeking treatment and its advantages and disadvantages. The session aims to ensure an understanding of the typical clinical pathway of PGT, and how regulation works in the UK, appreciate the embryology lab processes required , to familiarise attendees with the latest genetic diagnostic technologies and clinical scenarios will also be presented. This study day will be of interest to ATSM candidates, Consultants, ART specialists, Nurses, Embryologists and Counsellors.
| Session | Speaker |
|---|---|
| Welcome from the Chair | Tarek El-Toukhy |
| Introduction to genetic diseases, their mode of inheritance and their burden on health and reproduction | Anne Lampe |
| Reproductive options available to couples at risk | Yacoub Khalaf |
| The current status of NIPT and prenatal diagnosis | Kathy Mann |
| An introduction to PGT and expanded carrier screening | Tazeen Ashraf |
| PGD counselling and clinical pathway | Charlotte Tomlinson |
| Embryology of PGT | Alpesh Doshi |
| PGT diagnostic technologies | Roy Pascal Naja |
| Clinical assessment/ preparation of PGT couples and factors that affect success and clinical results | Tarek El-Toukhy |
| How does the HFEA regulate PGT? | Anne Lampe |
| PGT Service Delivery Models Pitfalls and Trouble shooting in a Satellite PGT service | Emma Sowerby |
| Training in PGT – the who and the how | Alison Lashwood |
| What is the Role of PGT-A in an evidence-based IVF practice? | Bulent Urman |